TICKERNOMICS Sign up
Last Update: 2024-12-27 15:21:43
ALCON INC ( ALC ) https://www.alcon.com
86.30USD
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Country:
Switzerland
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
ALC
11.01%
SPY
32.66%
ALC
0.23%
SPY
108.59%
ALC
53.79%
SPY
302.52%
ALC
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
42951.51
46546.51
0.40
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
37.00
4.34
2.05
2.45
0.31
23.57
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
13.53
55.87
19.99
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
8.0368
4.36
5.04
1.01
Other Earnings and Cash Flow Stats:
ALCON INC ( ALC ) Net Income TTM ($MM) is 1161.00
ALCON INC ( ALC ) Operating Income TTM ($MM) is 1472.18
ALCON INC ( ALC ) Owners' Earnings Annual ($MM) is 0.00
ALCON INC ( ALC ) Current Price to Owners' Earnings ratio is 0.00
ALCON INC ( ALC ) EBITDA TTM ($MM) is 2416.96
ALCON INC ( ALC ) EBITDA Margin is 19.99%
Capital Allocation:
ALCON INC ( ALC ) has paid 0.26 dividends per share and bought back -1.4 million shares in the past 12 months
ALCON INC ( ALC ) has increased its debt by 12.0 million USD in the last 12 months
Capital Structure:
ALCON INC ( ALC ) Interest-bearing Debt ($MM) as of last quarter is 5161
ALCON INC ( ALC ) Annual Working Capital Investments ($MM) are 31
ALCON INC ( ALC ) Book Value ($MM) as of last quarter is 20926
ALCON INC ( ALC ) Debt/Capital as of last quarter is 24%
Other Balance Sheet Stats:
ALCON INC ( ALC ) has 1566 million in cash on hand as of last quarter
ALCON INC ( ALC ) has 2340 million of liabilities due within 12 months, and long term debt 4686 as of last quarter
ALCON INC ( ALC ) has 497 common shares outstanding as of last quarter
ALCON INC ( ALC ) has 0 million USD of preferred stock value
Academic Scores:
ALCON INC ( ALC ) Altman Z-Score is 3.57 as of last quarter
ALCON INC ( ALC ) Piotroski Score is 6.00 as of last quarter
Corporate Governance:
ALCON INC ( ALC ) largest shareholder is owning shares at 0.00 ($MM) value
(an insider) shares of ALCON INC ( ALC ) for the amount of $ on
0.14% of ALCON INC ( ALC ) is held by insiders, and 66.66% is held by institutions
ALCON INC ( ALC ) went public on 2019-04-09
Other ALCON INC ( ALC ) financial metrics:
FCF:1090.36
Unlevered Free Cash Flow:0.00
EPS:2.11
Operating Margin:13.53
Gross Profit Margin:55.87
Div. Payout Ratio%:11.32
Div. Growth YoY%:-42.48
Equity Return%:4.26
Beta:1.01
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About ALCON INC ( ALC ) :
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx laser system, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.